461 related articles for article (PubMed ID: 31385256)
21. Identification of new-onset atrial fibrillation after cardiac surgery in Vietnam. A feasibility study of a novel screening strategy in a limited-resource setting: study protocol.
Ngo THL; Vu VB; Nguyen CH; Le TD; Hoang TK; Freedman B; Lowres N
BMJ Open; 2018 Sep; 8(9):e020800. PubMed ID: 30181182
[TBL] [Abstract][Full Text] [Related]
22. Feasibility of extended ambulatory electrocardiogram monitoring to identify silent atrial fibrillation in high-risk patients: the Screening Study for Undiagnosed Atrial Fibrillation (STUDY-AF).
Turakhia MP; Ullal AJ; Hoang DD; Than CT; Miller JD; Friday KJ; Perez MV; Freeman JV; Wang PJ; Heidenreich PA
Clin Cardiol; 2015 May; 38(5):285-92. PubMed ID: 25873476
[TBL] [Abstract][Full Text] [Related]
23. Feasibility and outcomes of atrial fibrillation screening using intermittent electrocardiography in a primary healthcare setting: A cross-sectional study.
Ghazal F; Theobald H; Rosenqvist M; Al-Khalili F
PLoS One; 2018; 13(5):e0198069. PubMed ID: 29795689
[TBL] [Abstract][Full Text] [Related]
24. Clinical Relevance of Orthostatic Hypotension in Patients with Atrial Fibrillation and Suspected Transient Ischemic Attack.
Mankoo AS; Minhas JS; Coles B; Hussain ST; Khunti K; Robinson TG; Mistri AK; Eveson DJ;
High Blood Press Cardiovasc Prev; 2020 Feb; 27(1):93-101. PubMed ID: 32048202
[TBL] [Abstract][Full Text] [Related]
25. Screening for atrial fibrillation in patients aged 65 years or over attending annual flu vaccination clinics at a single general practice.
Rhys GC; Azhar MF; Foster A
Qual Prim Care; 2013; 21(2):131-40. PubMed ID: 23735694
[TBL] [Abstract][Full Text] [Related]
26. Effectiveness of a nongovernmental organization-led large-scale community atrial fibrillation screening program using the smartphone electrocardiogram: An observational cohort study.
Chan NY; Choy CC; Chan CK; Siu CW
Heart Rhythm; 2018 Sep; 15(9):1306-1311. PubMed ID: 29890321
[TBL] [Abstract][Full Text] [Related]
27. Detection of Atrial Fibrillation Using a Home Blood Pressure Monitor.
Balanis T; Sanner B
Vasc Health Risk Manag; 2021; 17():407-414. PubMed ID: 34285495
[TBL] [Abstract][Full Text] [Related]
28. Opportunistic atrial fibrillation screening in primary care in Ireland: results of a pilot screening programme.
Callanan A; Quinlan D; Kearney PM; O'Sullivan S; Zhi GTY; Crichton A; Howell MW; Bradley C; Buckley C
Open Heart; 2024 May; 11(1):. PubMed ID: 38724265
[TBL] [Abstract][Full Text] [Related]
29. Assessment of a non-physician screening program for hypertension and cardiovascular risk in community pharmacies.
Pappaccogli M; Ravetto Enri L; Perlo E; Di Monaco S; Pignata I; Baratta F; Rabbia F; Mana M; Veglio F; Brusa P
Nutr Metab Cardiovasc Dis; 2019 Dec; 29(12):1316-1322. PubMed ID: 31383504
[TBL] [Abstract][Full Text] [Related]
30. Opportunistic screening for atrial fibrillation in a rural area.
Smyth B; Marsden P; Corcoran R; Walsh R; Brennan C; McSharry K; Clarke J; Kelly PJ; Harbison J
QJM; 2016 Aug; 109(8):539-543. PubMed ID: 26819299
[TBL] [Abstract][Full Text] [Related]
31. Atrial fibrillation detection with a portable device during cardiovascular screening in primary care.
Diamantino AC; Nascimento BR; Beaton AZ; Nunes MCP; Oliveira KKB; Rabelo LC; Barbosa MM; Tompsett AR; Olivieri L; Mata MD; Costa WAA; Pereira AF; Diamantino LC; Ribeiro ALP; Sable C; Brant LCC
Heart; 2020 Aug; 106(16):1261-1266. PubMed ID: 32019822
[TBL] [Abstract][Full Text] [Related]
32. Pharmacists detecting atrial fibrillation (PDAF) in primary care during the influenza vaccination season: a multisite, cross-sectional screening protocol.
Veale EL; Stewart AJ; Mathie A; Lall SK; Rees-Roberts M; Savickas V; Bhamra SK; Corlett SA
BMJ Open; 2018 Mar; 8(3):e021121. PubMed ID: 29540425
[TBL] [Abstract][Full Text] [Related]
33. Curricular-driven screening for atrial fibrillation at community pharmacies.
Bleske BE; Raley RE; Hunter TS; Anderson JR
J Am Pharm Assoc (2003); 2022; 62(2):541-545.e1. PubMed ID: 34772632
[TBL] [Abstract][Full Text] [Related]
34. Cost-effectiveness and screening performance of ECG handheld machine in a population screening programme: The Belgian Heart Rhythm Week screening programme.
Proietti M; Farcomeni A; Goethals P; Scavee C; Vijgen J; Blankoff I; Vandekerckhove Y; Lip GY; Mairesse GH;
Eur J Prev Cardiol; 2019 Jun; 26(9):964-972. PubMed ID: 30935219
[TBL] [Abstract][Full Text] [Related]
35. A prospective 5-year follow-up after population-based systematic screening for atrial fibrillation.
Engdahl J; Holmén A; Rosenqvist M; Strömberg U
Europace; 2018 Nov; 20(FI_3):f306-f311. PubMed ID: 29688312
[TBL] [Abstract][Full Text] [Related]
36. General population screening for atrial fibrillation with an automated rhythm-detection blood pressure device.
Denas G; Battaggia A; Fusello M; Franco-Novelletto B; Cancian M; Scalisi A; Pengo V
Int J Cardiol; 2021 Jan; 322():265-270. PubMed ID: 32882292
[TBL] [Abstract][Full Text] [Related]
37. Screening for atrial fibrillation in 13 122 Hong Kong citizens with smartphone electrocardiogram.
Chan NY; Choy CC
Heart; 2017 Jan; 103(1):24-31. PubMed ID: 27733533
[TBL] [Abstract][Full Text] [Related]
38. Atrial fibrillation requiring urgent medical care. Approach and outcome in the various departments of admission. Data from the atrial Fibrillation/flutter Italian REgistry (FIRE).
Santini M; De Ferrari GM; Pandozi C; Alboni P; Capucci A; Disertori M; Gaita F; Lombardi F; Maggioni AP; Mugelli A; Salerno-Uriarte JA; Sermasi S; Schwartz PJ;
Ital Heart J; 2004 Mar; 5(3):205-13. PubMed ID: 15119503
[TBL] [Abstract][Full Text] [Related]
39. Predicting Determinants of Atrial Fibrillation or Flutter for Therapy Elucidation in Patients at Risk for Thromboembolic Events (PREDATE AF) Study.
Nasir JM; Pomeroy W; Marler A; Hann M; Baykaner T; Jones R; Stoll R; Hursey K; Meadows A; Walker J; Kindsvater S
Heart Rhythm; 2017 Jul; 14(7):955-961. PubMed ID: 28506913
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of Atrial Fibrillation and Antithrombotic Therapy in Hemodialysis Patients: Cross-Sectional Results of the Vienna InVestigation of AtriaL Fibrillation and Thromboembolism in Patients on HemoDIalysis (VIVALDI).
Königsbrügge O; Posch F; Antlanger M; Kovarik J; Klauser-Braun R; Kletzmayr J; Schmaldienst S; Auinger M; Zuntner G; Lorenz M; Grilz E; Stampfel G; Steiner S; Pabinger I; Säemann M; Ay C
PLoS One; 2017; 12(1):e0169400. PubMed ID: 28052124
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
